oxamniquine has been researched along with Chronic Disease in 5 studies
Oxamniquine: An anthelmintic with schistosomicidal activity against Schistosoma mansoni, but not against other Schistosoma spp. Oxamniquine causes worms to shift from the mesenteric veins to the liver where the male worms are retained; the female worms return to the mesentery, but can no longer release eggs. (From Martindale, The Extra Pharmacopoeia, 31st ed, p121)
oxamniquine : A racemate comprising equimolar amounts of (R)- and (S)-oxamniquine. An anthelmintic, it is administered orally for the treatment of schistomiasis caused by Schistosoma mansoni (but not by other Schistosoma species); intramuscular administration is no longer used as it causes severe pain at the injection site.
{2-[(isopropylamino)methyl]-7-nitro-1,2,3,4-tetrahydroquinolin-6-yl}methanol : A member of the class of quinolines that is 1,2,3,4-tetrahydroquinoline which is substituted at positions 2, 6, and 7 by (isopropylamino)methyl, hydroxymethyl, and nitro groups, respectively.
Chronic Disease: Diseases which have one or more of the following characteristics: they are permanent, leave residual disability, are caused by nonreversible pathological alteration, require special training of the patient for rehabilitation, or may be expected to require a long period of supervision, observation, or care (Dictionary of Health Services Management, 2d ed). For epidemiological studies chronic disease often includes HEART DISEASES; STROKE; CANCER; and diabetes (DIABETES MELLITUS, TYPE 2).
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (40.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (40.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Faria-Pinto, Pd | 1 |
| Montesano, MA | 1 |
| Jacinto, AA | 1 |
| Santos, RS | 1 |
| Bordin, FH | 1 |
| Ferreira, AP | 1 |
| Penido, ML | 1 |
| Coelho, PM | 2 |
| Vasconcelos, EG | 1 |
| Carvalho, MG | 1 |
| Mello, RT | 1 |
| Soares, AL | 1 |
| Bicalho, RS | 1 |
| Lima e Silva, FC | 1 |
| Andrade, ZA | 1 |
| Baptista, AP | 1 |
| Santana, TS | 1 |
| Lambertucci, JR | 1 |
| Greco, DB | 1 |
| Pedroso, ER | 1 |
| da Costa Rocha, MO | 1 |
| Salazar, HM | 1 |
| de Lima, DP | 1 |
| el-Rooby, A | 1 |
1 review available for oxamniquine and Chronic Disease
| Article | Year |
|---|---|
Management of hepatic schistosomiasis.
Topics: Acute Disease; Animals; Central Nervous System; Child; Chronic Disease; Colon; Diagnosis, Differenti | 1985 |
1 trial available for oxamniquine and Chronic Disease
| Article | Year |
|---|---|
A double blind trial with oxamniquine in chronic schistosomiasis mansoni.
Topics: Adolescent; Child; Chronic Disease; Clinical Trials as Topic; Double-Blind Method; Feces; Female; Hu | 1982 |
3 other studies available for oxamniquine and Chronic Disease
| Article | Year |
|---|---|
Antibody reactivity against potato apyrase, a protein that shares epitopes with Schistosoma mansoni ATP diphosphohydrolase isoforms, in acute and chronically infected mice, after chemotherapy and reinfection.
Topics: Acute Disease; Animals; Anthelmintics; Antibodies, Helminth; Antigens, Helminth; Apyrase; Chronic Di | 2010 |
Murine schistosomiasis mansoni: process of blood coagulation at pre-patent, acute and chronic phases, and consequence of chemotherapeutic cure on the reversion of changes.
Topics: Acute Disease; Animals; Blood Coagulation; Blood Coagulation Factors; Chronic Disease; Female; Mice; | 2005 |
Remodeling of hepatic vascular changes after specific chemotherapy of schistosomal periportal fibrosis.
Topics: Animals; Anthelmintics; Chronic Disease; Disease Models, Animal; Female; Granuloma; Humans; Liver Ci | 2006 |